Key result
Persistently high FIB-4 index is linked to ~73% higher incident heart failure risk in type 2 diabetes.
Why the study?
The prognostic relevance of serial Fibrosis-4 index changes for incident heart failure in type 2 diabetes mellitus remains unclear.
Does serial FIB-4 variability and longitudinal persistent elevation predict incident heart failure independently of chronological age in patients with type 2 diabetes?
Cohort (n=8,221)
No
Does serial FIB-4 variability and longitudinal persistent elevation predict incident heart failure independently of chronological age in patients with type 2 diabetes?
Hazard Ratio: 1.73 (95% CI 1.35–2.2)
Absolute Event Rate: 30.6% vs 21.7%
p-value: p=<0.001
Greater within-person FIB-4 variability and persistently high FIB-4 levels are independently associated with an increased risk of incident heart failure in patients with type 2 diabetes.
Background The prognostic relevance of serial Fibrosis-4 index (FIB-4) changes for incident heart failure (HF) in type 2 diabetes mellitus (T2DM) remains unclear. We examined whether within-person FIB-4 variability and longitudinal patterns were associated with HF after explicit adjustment for chronological age. Methods Routinely collected clinical data from 2000 to 2025 were analyzed using a 24-month landmark design. FIB-4 measurements from months 0 to 18 defined the exposure, followed by a 6-month lag before HF follow-up. Variability was calculated as the within-person standard deviation of log 2 -transformed FIB-4. Using a threshold of 2.67, patients were classified as never high, improving from high, worsening to high, or persistently high. Associations with incident HF were estimated using multivariable Cox regression. Results Among 8,221 patients, 1,811 developed HF during 50,640 person-years. Greater FIB-4 variability was associated with a higher HF hazard (adjusted hazard ratio [HR], 1.73; 95% confidence interval [CI], 1.43–2.09). Compared with the never-high pattern, persistent-high FIB-4 (HR, 1.73; 95% CI, 1.35–2.20) and worsening to high (HR, 1.28; 95% CI, 1.01–1.62) were associated with higher HF hazards, whereas improving from high was not (HR, 0.95; 95% CI, 0.70–1.28). Adding serial FIB-4 features resulted in a small, statistically uncertain improvement in temporal-validation discrimination (ΔC-index, 0.0069; 95% CI, −0.0043 to 0.0190). Discussion Serial FIB-4 variability and persistent elevation were associated with incident HF independently of chronological age. These measures may characterize longitudinal multisystem cardiometabolic burden, but their incremental predictive value was limited. External validation is required before clinical application.
No takes yet. Share an insight, caveat, or question.
Nagy et al. (2026) conducted a cohort in Type 2 diabetes mellitus (n=8,221). Persistent-high Fibrosis-4 (FIB-4) index (≥2.67) vs. Never-high FIB-4 index (<2.67) was evaluated on Incident heart failure (HR 1.73, 95% CI 1.35-2.20, p=<0.001). Compared with a never-high pattern, a persistently high Fibrosis-4 (FIB-4) index was associated with a 73% higher hazard of incident heart failure (HR 1.73) among patients with type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: